Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | State and School Employees' Health Insurance Plan - Apomorphine | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | State and School Employees' Health Insurance Plan - Anti-Rheumatic Biologicals | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | State and School Employees' Health Insurance Plan - Analysis of Human DNA in Stool Samples as a Technique for Colorectal Cancer Screening | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | State and School Employees' Health Insurance Plan - Amtagvi (lifileucel) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | State and School Employees' Health Insurance Plan - Alpha-1 Proteinase Inhibitors | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | State and School Employees' Health Insurance Plan - Agents for Recurrent Clostridioides Difficile | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | State and School Employees' Health Insurance Plan - Adakveo (crizanlizumab-tmca) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | State and School Employees' Health Insurance Plan - Actimmune (interferon gamma-1b) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | State and School Employees' Health Insurance Plan - ACTH Gel (Repository Corticotropin Injection) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Spravato (esketamine) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Spinraza (nusinersen) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Spinal Cord and Dorsal Root Ganglion Stimulation | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Sphenopalatine Ganglion Block for Headache | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Speech Therapy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Special and Immunohistochemical Stains for Microscopic Evaluation of Esophageal and Gastric Tissue | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Soriatane (acitretin) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Somatic Genetic Testing To Select Individuals with Melanoma or Glioma for Targeted Therapy (BRAF) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Somatic Biomarker Testing for Immune Checkpoint Inhibitor Therapy (BRAF, MSI/MMR, PD-L1, TMB) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment in Non-Small-Cell Lung Cancer (EGFR, ALK, BRAF, ROS1, RET, MET, KRAS, NTRK) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment in Metastatic Colorectal Cancer (KRAS, NRAS, BRAF, and HER2) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Solaraze 3% (diclofenac) Gel | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Small Bowel/Liver and Multivisceral Transplant | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Sleep Disorders | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Skin Contact Monochromatic Infrared Energy as a Technique to Treat Cutaneous Ulcers, Diabetic Neuropathy and Miscellaneous Musculoskeletal Conditions | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Signal-Averaged Electrocardiography (ECG)(SAECG) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Serum Holo-Transcobalamin as a Marker of Vitamin B12 (i.e., Cobalamin) Status | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Serum Biomarker Tests for Multiple Sclerosis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Serum Biomarker Panel Testing for Systemic Lupus Erythematosus and Other Connective Tissue Diseases | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Serum Biomarker Human Epididymis Protein 4 (HE4) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Serologic Testing for Helicobacter Pylori | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Serologic Genetic and Molecular Screening for Colorectal Cancer | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Serologic Diagnosis of Celiac Disease | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Sensory Stimulation for Coma Patients | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Sensory Integration Therapy and Auditory Integration Therapy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Semi-Implantable and Fully Implantable Middle Ear Hearing Aids | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Selected Positron Emission Tomography Technologies for Evaluation of Alzheimer Disease | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Screening Services and Procedures | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Screening for Lung Cancer Using Computed Tomography (CT) Scanning | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Scintimammography and Gamma Imaging of the Breast and Axilla | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Scenesse (afamelanotide) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Savella (milnacipran) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Saturation Biopsy for Diagnosis, Staging, and Management of Prostate Cancer | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Sacral Nerve Neuromodulation/Stimulation | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Ryzneuta (efbemalenograstim alfa-vuxw) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Ryoncil (remestemcel-L-rknd) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Rolvedon (eflapegrastim-xnst) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Rituximab Non-Oncology | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Risk-Reducing Medications for Primary Breast Cancer | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Risk-Reducing Mastectomy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Rhinoplasty | New policy |